Celon Pharma S.A. (WSE:CLN)
Poland flag Poland · Delayed Price · Currency is PLN
24.05
-0.45 (-1.84%)
Apr 17, 2025, 5:00 PM CET

Celon Pharma Revenue

Celon Pharma had revenue of 51.05M PLN in the quarter ending September 30, 2024, with 5.64% growth. This brings the company's revenue in the last twelve months to 209.54M, down -2.30% year-over-year. In the year 2023, Celon Pharma had annual revenue of 213.92M with 10.33% growth.

Revenue (ttm)
209.54M
Revenue Growth
-2.30%
P/S Ratio
6.18
Revenue / Employee
372.84K
Employees
515
Market Cap
1.30B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023213.92M20.04M10.33%
Dec 31, 2022193.89M-2.20M-1.12%
Dec 31, 2021196.09M38.64M24.54%
Dec 31, 2020157.45M55.20M53.99%
Dec 31, 2019102.25M-23.00M-18.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.61B
Synektik Spólka Akcyjna 556.63M
Voxel 507.77M
Ryvu Therapeutics 101.96M
Selvita 345.76M
Centrum Medyczne ENEL-MED 680.32M
Scope Fluidics 119.00K
EMC Instytut Medyczny 809.41M
Revenue Rankings